Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS, Armstrong MJ, Gloss D, Potrebic S, Jankovic J, Karp BP, Naumann M, So YT, Yablon SA. Simpson DM, et al. Among authors: comella cl. Neurology. 2016 May 10;86(19):1818-26. doi: 10.1212/WNL.0000000000002560. Epub 2016 Apr 18. Neurology. 2016. PMID: 27164716 Free PMC article.
Benefits and risks of pharmacological treatments for essential tremor.
Lyons KE, Pahwa R, Comella CL, Eisa MS, Elble RJ, Fahn S, Jankovic J, Juncos JL, Koller WC, Ondo WG, Sethi KD, Stern MB, Tanner CM, Tintner R, Watts RL. Lyons KE, et al. Among authors: comella cl. Drug Saf. 2003;26(7):461-81. doi: 10.2165/00002018-200326070-00003. Drug Saf. 2003. PMID: 12735785 Review.
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Simpson DM, Blitzer A, Brashear A, Comella C, Dubinsky R, Hallett M, Jankovic J, Karp B, Ludlow CL, Miyasaki JM, Naumann M, So Y; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Simpson DM, et al. Among authors: comella c. Neurology. 2008 May 6;70(19):1699-706. doi: 10.1212/01.wnl.0000311389.26145.95. Neurology. 2008. PMID: 18458230 Free PMC article.
Treatment of focal dystonias with botulinum neurotoxin.
Hallett M, Benecke R, Blitzer A, Comella CL. Hallett M, et al. Among authors: comella cl. Toxicon. 2009 Oct;54(5):628-33. doi: 10.1016/j.toxicon.2008.12.008. Epub 2008 Dec 13. Toxicon. 2009. PMID: 19103214 Free PMC article. Review.
Early-onset primary dystonia.
Robottom BJ, Weiner WJ, Comella CL. Robottom BJ, et al. Among authors: comella cl. Handb Clin Neurol. 2011;100:465-79. doi: 10.1016/B978-0-444-52014-2.00036-7. Handb Clin Neurol. 2011. PMID: 21496603 Review.
189 results